IMPE Abstracts

Background: Since August 1985 we started a neonatal screening program for 1) Congenital Hypothyroidism (CH) and 2) Phenylketonuria /Hyperphenylalaninemias PKU/HPA) adding to the program in 1997 3) Cystic Fibrosis (FQ) 4) Galactosemia (GAL) and 5) Congenital Adrenal Hyperplasia (CAH), in 2006 6) Biotinidase Deficiency (BD) and in 2013 7) Maple syrup disease (MSUD).Objective: To Communicate the results of the implemented p...